Compare
Nuo Therapeutics, Inc. vs IceCure Medical Ltd. vs OSR Health, Inc. vs Tenon Medical, Inc.
| Latest fiscal year | Nuo Therapeutics, Inc. AURX | IceCure Medical Ltd. ICCM | OSR Health, Inc. OSRH | Tenon Medical, Inc. TNON |
|---|---|---|---|---|
| Year ended | 2025-12-31 | 2025-12-31 | 2025-12-31 | 2025-12-31 |
| Revenue | $3.31M | $3.38M | $2.91M | $3.94M |
| Revenue growth (YoY) | +142.7% | +2.7% | -17.7% | +20.4% |
| Gross margin | 66.9% | 36.3% | 20.4% | 59.8% |
| Operating margin | -76.0% | -446.7% | -631.0% | -324.3% |
| Net margin | -75.8% | -445.6% | -931.2% | -318.4% |
| Net income | -$2.51M | -$15.06M | -$27.06M | -$12.56M |
| EPS (Diluted) | n/a | $0.24 | -$0.80 | -$1.70 |
| Operating cash flow | -$865.0K | -$14.57M | -$4.33M | -$10.74M |
| Free cash flow | -$1.14M | -$14.61M | n/a | -$11.02M |
| Cash & equivalents | $548.9K | $8.90M | $1.70M | $3.76M |
| Total assets | $1.85M | $13.89M | $171.24M | $10.76M |
| Total liabilities | $2.80M | n/a | $44.20M | $5.72M |
| Shareholders' equity | -$956.6K | $9.05M | $127.04M | $5.04M |
| Return on year-end equity | n/a | -166.4% | -21.3% | -249.1% |
| Shares outstanding | 48.18M | 73.12M | 26.60M | 10.85M |
Revenue, most recent five fiscal years
| Fiscal year | Nuo Therapeutics, Inc. | IceCure Medical Ltd. | OSR Health, Inc. | Tenon Medical, Inc. |
|---|---|---|---|---|
| Latest | $3.31M Ended 2025-12-31 | $3.38M Ended 2025-12-31 | $2.91M Ended 2025-12-31 | $3.94M Ended 2025-12-31 |
| 1 year earlier | $1.37M Ended 2024-12-31 | $3.29M Ended 2024-12-31 | $3.53M Ended 2024-12-31 | $3.28M Ended 2024-12-31 |
| 2 years earlier | $608.5K Ended 2023-12-31 | $3.23M Ended 2023-12-31 | n/a | $2.93M Ended 2023-12-31 |
| 3 years earlier | $112.2K Ended 2022-12-31 | $3.08M Ended 2022-12-31 | n/a | $691.0K Ended 2022-12-31 |
| 4 years earlier | $0 Ended 2021-12-31 | $4.14M Ended 2021-12-31 | n/a | $160.0K Ended 2021-12-31 |